Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07CER
|
|||
Former ID |
DNC009973
|
|||
Drug Name |
1-Biphenyl-4-ylmethylmaleimide
|
|||
Synonyms |
CHEMBL576859; 1-Biphenyl-4-ylmethylmaleimide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H13NO2
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(C=C2)CN3C(=O)C=CC3=O
|
|||
InChI |
1S/C17H13NO2/c19-16-10-11-17(20)18(16)12-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-11H,12H2
|
|||
InChIKey |
LMMOMHSYMJTOJF-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 913733-40-1
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. J Med Chem. 2009 Dec 10;52(23):7410-20. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.